Ms. magazine  -- more than a magazine a movement

SIGN UP FOR MS. DIGEST, JOBS, NEWS AND ALERTS

FEMINIST WIRE NEWSBRIEFS

ABOUT
SEE CURRENT ISSUE
SHOP MS. STORE
MS. IN THE CLASSROOM
FEMINIST DAILY WIRE
FEMINIST RESOURCES
PRESS
JOBS AT MS.
READ BACK ISSUES
CONTACT
RSS (XML)
 
feminist wire | daily newsbriefs

December-01-03

State Medicaid in New Mexico to Cover Abortion Pill

In August, New Mexico Governor Bill Richardson rewrote state Medicaid rules to include coverage of abortion pills in cases that are deemed medically necessary. The Albuquerque Tribune reported that Gov. Richardson made changes to the rules because their vague wording precluded doctors from getting reimbursement for disbursing drugs, only pharmacists could be reimbursed for drug distribution. Because doctors must distribute the abortion pill mifepristone, commonly referred to as RU-486, the rule in effect barred Medicaid patients from receiving a medically necessary procedure. The new language was written broadly to cover all oral medications that are used for terminating a pregnancy to cover any pills that come into the market in addition to mifepristone.

The Associated Press reports that most private health insurance plans have covered mifepristone since 2000 when it went on the market. "For low-income women to not have this kind of insurance was a real slap in the face," Dr. Bruce Ferguson, an Albuquerque physician told the Albuquerque Tribune. "This is a big step forward. It gives the poor the same options as women who have jobs and insurance."

The Feminist Majority Foundation has been leading a campaign to increase clinical trials and research into the potential uses of mifepristone to treat fibroids, endometriosis, breast cancer, uterine cancer, ovarian cancer, and other serious illnesses. However, efforts by anti-abortion extremists, including a petition to the Food and Drug Administration asking for a review of FDA approval for the drug, have severely limited access for women in the US to a potentially lifesaving drug.

LEARN MORE Access to Mifepristone

DONATE to FMF's campaign for mifepristone research

Media Resources: Albuquerque Tribune 11/11/03; Associated Press 11/12/03


© Feminist Majority Foundation, publisher of Ms. magazine

If you liked this story, consider making a tax-deductible donation to support Ms. magazine.

 

 

Send to a Friend
Their
Your
Comments
(optional)


More Feminist News

1/27/2016 Study Exposes 'Gender Gap' in Media Coverage of Reproductive Issues - A new study by the Women's Media Center has revealed more than half of news stories focusing on reproductive issues are written by men. According to WMC Media Watch: the Gender Gap in Coverage of Reproductive Issues, men penned 52 percent of bylines discussing issues of reproductive health care - including contraception and abortion - compared to just 37 percent by women. . . .
 
1/27/2016 Taiwan Elects First Woman President - In a landslide victory, the leader of Taiwan's Democratic Progressive Party (DPP) Tsai Ing-wen won the country's presidential election, becoming the first woman in Taiwan's history to hold the position. Emphasizing her party's commitment to maintaining Taiwan's independence from China, Tsai won over young voters eager to usher in a political changing of the guard following some 70 years of dominance by the pro-Chinese unification party, the Kuomintang (KMT), chaired by presidential opponent Eric Chu. . . .
 
1/26/2016 Anti-Abortion Extremists Behind Planned Parenthood Attack Videos Indicted - Two anti-abortion extremists responsible for last year's misleading videos attacking Planned Parenthood have been indicted on criminal charges by a grand jury in Houston, Texas. On Monday, Harris County district attorney Devon Anderson announced that David Daleiden, the director of the Center for Medical Progress (CMP) - the group behind deceptive videos falsely accusing Planned Parenthood of illegally selling fetal tissue - was indicted on a felony charge of tampering with a governmental record and on a misdemeanor charge related to the purchasing of human organs. . . .